{"id":"https://openalex.org/W7224116263","doi":"https://doi.org/10.3389/fmed.2026.1943515","title":"CT-defined sarcopenia and outcomes in HR+/HER2\u2212 metastatic breast cancer treated with CDK4/6 inhibitors","display_name":"CT-defined sarcopenia and outcomes in HR+/HER2\u2212 metastatic breast cancer treated with CDK4/6 inhibitors","publication_year":2026,"publication_date":"2026-10-28","ids":{"openalex":"https://openalex.org/W7224116263","doi":"https://doi.org/10.3389/fmed.2026.1943515"},"language":"en","primary_location":{"id":"doi:10.3389/fmed.2026.1943515","doi":"https://doi.org/10.3389/fmed.2026.1943515","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1943515","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1943515/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1943515/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5137394836","display_name":"Zeynep Alaca Topcu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I57913696","display_name":"Istanbul Medeniyet University","ror":"https://ror.org/05j1qpr59","country_code":"TR","type":"education","lineage":["https://openalex.org/I57913696"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Zeynep Alaca Topcu","raw_affiliation_strings":["Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology","institution_ids":["https://openalex.org/I57913696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080521312","display_name":"Zehra Sucuo\u011flu \u0130\u015fleyen","orcid":"https://orcid.org/0000-0002-0045-8009","observed_orcids":["https://orcid.org/0000-0002-0045-8009"]},"institutions":[{"id":"https://openalex.org/I3125175737","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi","ror":"https://ror.org/04z60tq39","country_code":"TR","type":"education","lineage":["https://openalex.org/I3125175737"]},{"id":"https://openalex.org/I4210155097","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi Hastanesi","ror":"https://ror.org/049aadf12","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I3125175737","https://openalex.org/I4210155097"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Zehra Sucuoglu Isleyen","raw_affiliation_strings":["Bezmialem Vakif University Hospital, Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bezmialem Vakif University Hospital, Department of Medical Oncology","institution_ids":["https://openalex.org/I3125175737","https://openalex.org/I4210155097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055942263","display_name":"\u0130smail Yurtsever","orcid":"https://orcid.org/0000-0001-7482-668X","observed_orcids":["https://orcid.org/0000-0001-7482-668X"]},"institutions":[{"id":"https://openalex.org/I3125175737","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi","ror":"https://ror.org/04z60tq39","country_code":"TR","type":"education","lineage":["https://openalex.org/I3125175737"]},{"id":"https://openalex.org/I4210155097","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi Hastanesi","ror":"https://ror.org/049aadf12","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I3125175737","https://openalex.org/I4210155097"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ismail Yurtsever","raw_affiliation_strings":["Bezmialem Vakif University Hospital, Department of Radiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bezmialem Vakif University Hospital, Department of Radiology","institution_ids":["https://openalex.org/I3125175737","https://openalex.org/I4210155097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069716603","display_name":"Bu\u011fra \u00d6ztosun","orcid":"https://orcid.org/0000-0003-2309-6781","observed_orcids":["https://orcid.org/0000-0003-2309-6781"]},"institutions":[{"id":"https://openalex.org/I57913696","display_name":"Istanbul Medeniyet University","ror":"https://ror.org/05j1qpr59","country_code":"TR","type":"education","lineage":["https://openalex.org/I57913696"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Bugra Oztosun","raw_affiliation_strings":["Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology","institution_ids":["https://openalex.org/I57913696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067880759","display_name":"Engin Erdemo\u011flu","orcid":"https://orcid.org/0000-0002-9235-8370","observed_orcids":["https://orcid.org/0000-0002-9235-8370"]},"institutions":[{"id":"https://openalex.org/I57913696","display_name":"Istanbul Medeniyet University","ror":"https://ror.org/05j1qpr59","country_code":"TR","type":"education","lineage":["https://openalex.org/I57913696"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Engin Erdemoglu","raw_affiliation_strings":["Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology","institution_ids":["https://openalex.org/I57913696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135193799","display_name":"Mehmet Be\u015firo\u011flu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I57913696","display_name":"Istanbul Medeniyet University","ror":"https://ror.org/05j1qpr59","country_code":"TR","type":"education","lineage":["https://openalex.org/I57913696"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mehmet Besiroglu","raw_affiliation_strings":["Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology","institution_ids":["https://openalex.org/I57913696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075835334","display_name":"Hac\u0131 Mehmet T\u00fcrk","orcid":"https://orcid.org/0000-0003-2206-8148","observed_orcids":["https://orcid.org/0000-0003-2206-8148"]},"institutions":[{"id":"https://openalex.org/I3125175737","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi","ror":"https://ror.org/04z60tq39","country_code":"TR","type":"education","lineage":["https://openalex.org/I3125175737"]},{"id":"https://openalex.org/I4210155097","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi Hastanesi","ror":"https://ror.org/049aadf12","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I3125175737","https://openalex.org/I4210155097"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Haci Mehmet Turk","raw_affiliation_strings":["Bezmialem Vakif University Hospital, Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bezmialem Vakif University Hospital, Department of Medical Oncology","institution_ids":["https://openalex.org/I3125175737","https://openalex.org/I4210155097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008382382","display_name":"Mahmut G\u00fcm\u00fc\u015f","orcid":"https://orcid.org/0000-0003-3550-9993","observed_orcids":["https://orcid.org/0000-0003-3550-9993"]},"institutions":[{"id":"https://openalex.org/I57913696","display_name":"Istanbul Medeniyet University","ror":"https://ror.org/05j1qpr59","country_code":"TR","type":"education","lineage":["https://openalex.org/I57913696"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mahmut Gumus","raw_affiliation_strings":["Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul Medeniyet University G\u00f6ztepe Prof Dr S\u00fcleyman Yal\u00e7\u0131n City Hospital, Department of Medical Oncology","institution_ids":["https://openalex.org/I57913696"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5137394836"],"corresponding_institution_ids":["https://openalex.org/I57913696"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83953333,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.8324999809265137,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.8324999809265137,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.13729999959468842,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sarcopenia","display_name":"sarcopenia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hr-her2-metastatic-breast-cancer","display_name":"HR+/HER2- metastatic breast cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.9789999723434448},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":1.0},{"id":"https://openalex.org/keywords/skeletal-muscle-index","display_name":"skeletal muscle index","score":0.9089999794960022},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.925000011920929},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.8980000019073486},{"id":"https://openalex.org/keywords/ct-imaging-biomarkers","display_name":"CT imaging biomarkers","score":0.4729999899864197},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.5759999752044678},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.46000000834465027},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.3140000104904175}],"concepts":[{"id":"https://openalex.org/C2776214593","wikidata":"https://www.wikidata.org/wiki/Q1787939","display_name":"Sarcopenia","level":2,"score":0.9811000227928162},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.927299976348877},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7111999988555908},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.6305999755859375},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6147000193595886},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5778999924659729},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.5514000058174133},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.49869999289512634},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4578999876976013},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45320001244544983},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4251999855041504},{"id":"https://openalex.org/C2779959927","wikidata":"https://www.wikidata.org/wiki/Q1048687","display_name":"Skeletal muscle","level":2,"score":0.4196000099182129},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.33059999346733093},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2992999851703644},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.2874999940395355},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.2761000096797943},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.27070000767707825}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fmed.2026.1943515","doi":"https://doi.org/10.3389/fmed.2026.1943515","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1943515","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1943515/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:1dde08704bd440a28a2cef96d3acb666","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1dde08704bd440a28a2cef96d3acb666","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Medicine, Vol 13 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmed.2026.1943515","doi":"https://doi.org/10.3389/fmed.2026.1943515","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1943515","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1943515/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224116263.pdf","grobid_xml":"https://content.openalex.org/works/W7224116263.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W2074514491","https://openalex.org/W2101398993","https://openalex.org/W2127424726","https://openalex.org/W2145280166","https://openalex.org/W2150134401","https://openalex.org/W2152963742","https://openalex.org/W2216184115","https://openalex.org/W2268912046","https://openalex.org/W2528767298","https://openalex.org/W2552099557","https://openalex.org/W2682393044","https://openalex.org/W2735943180","https://openalex.org/W2743199111","https://openalex.org/W2763875663","https://openalex.org/W2793551408","https://openalex.org/W2796428104","https://openalex.org/W2902371306","https://openalex.org/W2941465200","https://openalex.org/W2981414419","https://openalex.org/W3135204153","https://openalex.org/W4281688637","https://openalex.org/W4286631604","https://openalex.org/W4390946922","https://openalex.org/W4391091480","https://openalex.org/W4392369930","https://openalex.org/W4407230286","https://openalex.org/W4410610460","https://openalex.org/W4411976847","https://openalex.org/W4412403922","https://openalex.org/W7130642988","https://openalex.org/W7161063368"],"related_works":["https://openalex.org/W7130642988","https://openalex.org/W7129432273","https://openalex.org/W7161063368","https://openalex.org/W7156160990","https://openalex.org/W7161947489","https://openalex.org/W4410610460","https://openalex.org/W7161941092","https://openalex.org/W4412403922","https://openalex.org/W3014551793","https://openalex.org/W4392369930"],"abstract_inverted_index":{"Background":[0],"Sarcopenia":[1],"is":[2],"increasingly":[3],"recognized":[4],"as":[5],"a":[6,285],"potential":[7],"prognostic":[8,106,256],"factor":[9,257],"in":[10,18,40,124,133,142,147,170,178,261],"patients":[11,50,135,143,171,262,295],"with":[12,24,51,110,144,172,192,228,243,263],"cancer,":[13],"but":[14],"its":[15],"clinical":[16,38],"significance":[17],"HR+/HER2\u2212":[19,52,264],"metastatic":[20,53,265],"breast":[21,54,266],"cancer":[22,55,267],"treated":[23],"CDK4/6":[25,236,269],"inhibitors":[26],"remains":[27],"uncertain.":[28],"This":[29,44],"study":[30,47],"investigated":[31],"the":[32,75,83,95],"association":[33],"between":[34,64],"CT-defined":[35,111,129,187,251],"sarcopenia":[36,71,130,145,150,173,188,252],"and":[37,67,118,161,168,176,215,234,291,300],"outcomes":[39],"this":[41],"population.":[42],"Methods":[43],"retrospective":[45],"multicenter":[46],"included":[48],"94":[49],"who":[56],"received":[57],"ribociclib":[58],"or":[59],"palbociclib":[60],"plus":[61],"endocrine":[62],"therapy":[63,238],"January":[65],"2021":[66],"March":[68],"2024.":[69],"Baseline":[70],"was":[72,92,102,131,139,253],"defined":[73],"using":[74,94],"skeletal":[76,114,274],"muscle":[77,115,120,275],"index":[78,116],"measured":[79],"on":[80,277],"CT":[81,281],"at":[82],"third":[84],"lumbar":[85],"vertebral":[86],"level":[87],"(L3).":[88],"Progression-free":[89],"survival":[90],"(PFS)":[91],"estimated":[93],"Kaplan\u2013Meier":[96],"method.":[97],"Cox":[98],"proportional":[99],"hazards":[100],"regression":[101],"used":[103],"to":[104],"identify":[105,294],"factors":[107],"for":[108,288],"PFS,":[109],"sarcopenia,":[112,181],"continuous":[113,205],"(SMI),":[117],"total":[119],"area":[121],"(TMA)":[122],"evaluated":[123],"separate":[125,184],"multivariable":[126,185],"models.":[127,249],"Results":[128],"present":[132],"37":[134],"(39.4%).":[136],"Median":[137],"PFS":[138,164,194,245,260],"markedly":[140],"shorter":[141,193,244],"than":[146],"those":[148,179],"without":[149,180],"(15.2":[151],"vs.":[152],"26.6":[153],"months;":[154],"log-rank":[155],"p":[156,200,212,222],"<":[157,201],"0.001).":[158],"At":[159],"1":[160],"2":[162],"years,":[163],"rates":[165],"were":[166,225],"57.6%":[167],"15.2%":[169],"versus":[174],"84.1%":[175],"56.0%":[177],"respectively.":[182],"In":[183],"models,":[186],"remained":[189,240],"independently":[190,226],"associated":[191,227,242],"(HR,":[195,207,217],"3.22;":[196],"95%":[197,209,219],"CI,":[198,210,220],"1.86\u20135.59;":[199],"0.001),":[202],"whereas":[203],"higher":[204],"SMI":[206],"0.93;":[208],"0.89\u20130.97;":[211],"=":[213,223],"0.001)":[214],"TMA":[216],"0.97;":[218],"0.96\u20130.99;":[221],"0.002)":[224],"longer":[229],"PFS.":[230],"Higher":[231],"Ki-67":[232],"expression":[233],"second-line":[235],"inhibitor":[237],"also":[239],"significantly":[241],"across":[246],"all":[247],"three":[248],"Conclusions":[250],"an":[254],"independent":[255],"of":[258,273],"inferior":[259],"receiving":[268],"inhibitor-based":[270],"therapy.":[271],"Assessment":[272],"mass":[276],"routinely":[278],"acquired":[279],"baseline":[280],"scans":[282],"may":[283,292],"offer":[284],"practical":[286],"tool":[287],"risk":[289],"stratification":[290],"help":[293],"requiring":[296],"more":[297],"intensive":[298],"follow-up":[299],"supportive":[301],"care.":[302]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-29T00:00:00"}